Reply from the authors Editor-Dr Toner raises some interesting points regarding our article on the revised Starling equation and glycocalyx model paradigm (RSE&GM) which we are pleased to respond to. 1 We recognize the turning point Dr Toner describes when a recovering patient sheds litres of oedema, and it seems to be a sign of recovery rather than the cause of it. We could not do more than speculate on the mechanism, but normalization of interstitial collagen fibre conformation and reversal of GAG hydration must be involved. The relevance of RSE&GM to the practice of perioperative goal-directed fluid therapy is immense. First, we need to consider where the patient is on the J-curve. We suspect that general anaesthesia tends to lower venous resistance more than arterial resistance, lowering both arterial and capillary pressure and so moving the J-point to the left. We know that the endothelial glycocalyx layer is reduced or compacted during anaesthesia and surgery, and it therefore seems prudent to prefer a colloid-free isotonic salt solution for stroke volume optimization until the transendothelial pressure difference has been restored to the J-point. Dr Toner correctly observes that we would only choose to include colloid molecules in our isotonic salt solution if we intend to take the patient substantially above the J-point and retard Jv, but if stroke volume optimization can be achieved around or below the J-point, a colloid-free isotonic salt solution will suffice. On Dr Toner's concern about tissue oedema, many anaesthetists use phenylephrine to preserve the mean arterial pressure after what they consider to be adequate fluid loading. The a-adrenoceptor agonist opposes anaesthetic-induced arteriolar relaxation, thereby keeping capillary pressure and Jv low, and is an effective anti-oedema strategy. As the patient recovers from circulatory side-effects of anaesthesia, phenylephrine is weaned off. With judicious vasopressor and diuretic therapy, it is our practice to take care not to allow patients to become fluid-overloaded in the days after surgery, whether or not the anaesthetist or surgeon chooses to use an intraoperative colloid solution. Dr Toner's assertion that the total volume of colloid used for optimization over several days is less compared with crystalloids is worth quantifying in his practice. It is widely asserted that colloid boluses are essential for goal-directed intra-operative fluid therapy, in spite of published evidence to the contrary. Future clinical studies need to include a group in which the haemodynamic goal is targeted by variable infusion of a colloid-free isotonic salt solution, and in which we allow excessive anaesthetic-induced vasodilation to be minimized by a judicious dose of an a-adrenoceptor agonist to protect capillary pressure. We should be concerned that there is very little published safety information on the effects of starches or gelatines on the endothelial glycocalyx layer British Journal of Anaesthesia 108 (6): 1035-44 (2012) 
